Cordex Pharma
470 Nautilus Street
Suite 300
La Jolla
California
92037
United States
Tel: 858-551-5700
Fax: 858-551-5704
Website: http://www.cordexpharma.com/
Email: info@cordexpharma.com
12 articles about Cordex Pharma
-
Cordex Pharma Retains WBB Securities to Explore Strategic Options
2/1/2010
-
Cordex Pharma Completes Production of ATPace(TM) Clinical Trial Material
6/29/2009
-
Cordex Pharma Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
6/22/2009
-
Cordex Pharma Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
6/2/2009
-
Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
4/8/2009
-
Cordex Pharma Files ATPace Formulation Patent
3/4/2009
-
Cordex Pharma Announces Strategic Master Services Equity Agreement with Cato BioVentures
2/23/2009
-
Cordex Pharma Submits to the FDA an Amended Special Protocol Assessment for ATPace
2/18/2009
-
Cordex Pharma Forms Heart Failure Medical Advisory Board
2/12/2009
-
Cordex Pharma Forms Heart Failure Medical Advisory Board
2/11/2009
-
Duska Therapeutics, Inc. Completes Corporate Name Change to Cordex Pharma
1/28/2009
-
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
1/26/2009